Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Clinical guides

Geriatric Depression Scale

Avatar photo Katy Piper
Last Updated: September 2, 2026
Key takeaways

Key takeaways

The Geriatric Depression Scale (GDS) is a 15-item and 30-item validated screening tool for identifying depression in older adults aged 55 and above.

GDS uses a simple yes/no response format to minimize confusion in elderly patients and takes 5-10 minutes to administer in a clinical or community setting.

GDS-15 scores of 0-4 indicate normal mood, 5-8 mild depression, 9-11 moderate depression, and 12-15 severe depression requiring further evaluation.

Practice management software like Pabau lets clinicians document, store, and track GDS scores over time within a secure clinical record.

Found our content helpful?

Download your free geriatric depression scale template

A validated 15-item and 30-item screening tool for identifying depression in older adults aged 55 and above, with yes/no response format and clinical scoring guidance.

Download template

The geriatric depression scale is a validated screening tool for spotting depression in older adults. It uses plain yes/no questions instead of the mood scales built for younger populations, so patients with early cognitive decline can complete it without confusion.

This guide covers the GDS versions, how to administer and score the short form, who it fits, and where it falls short. A free, downloadable template sits below.

What is the geriatric depression scale?

The geriatric depression scale is a validated screening tool designed specifically for assessing depression in older adults. Brink and Yesavage developed it in 1982 to address how depression presents differently in elderly patients. Older adults often report mood symptoms differently than younger adults, and comorbid medical conditions can mask or complicate a diagnosis.

The original geriatric depression scale contains 30 yes/no questions. In 1986, Sheikh and Yesavage released a 15-item short form (GDS-15) for faster administration in busy clinical settings. Both versions use simple yes/no responses rather than the Likert scales common in other mood assessments. The format was chosen deliberately to reduce cognitive burden in patients with age-related cognitive decline.

Why the GDS was developed for older adults

Traditional depression screening tools often include somatic items, physical symptoms like fatigue or sleep loss, that overlap with normal aging or chronic illness. The GDS prioritizes psychological symptoms, such as mood, interest, and emotional withdrawal, while minimizing medical confounds. This design makes it a natural fit alongside a fuller psychiatric evaluation in geriatric populations.

Geriatric depression scale versions: GDS-30, GDS-15, GDS-5, and GDS-4

Multiple versions of the geriatric depression scale have been validated to suit different clinical contexts. The choice of version depends on available time, setting (office, residential care, emergency department), and the patient’s cognitive status.

Version Items Time Best For
GDS-30 30 yes/no questions 10-15 minutes Comprehensive assessment, research, and detailed documentation
GDS-15 15 yes/no questions 5-10 minutes Primary care, routine screening, fast assessment
GDS-5 5 yes/no questions 2-3 minutes Rapid screening in emergency or time-limited settings
GDS-4 4 yes/no questions 1-2 minutes Ultra-brief screening in hospital or acute care

How to administer the GDS-15 short form

Administering the GDS-15 is straightforward and requires no special training, though clinical judgment is essential when interpreting responses. The yes/no format supports more consistent clinical documentation compared with open-ended depression narratives.

  1. Prepare the patient: Explain that you are asking about their mood and feelings over the past week. Reassure them there are no right or wrong answers. Seat the patient comfortably in a quiet space.
  2. Read questions aloud: Present each of the 15 items one at a time in a clear, calm voice. Allow the patient time to respond; do not rush. If hearing loss is present, face the patient directly and speak at a normal conversational volume.
  3. Record responses: Mark each answer as “yes” or “no” on the GDS-15 form. If a patient hesitates, say “whatever you feel is most true” to guide their choice.
  4. Sum the depression-weighted responses: Count the number of answers indicating depression (typically marked as 1 point each). Do not reverse-score; each depression-indicating answer equals 1 point.
  5. Interpret and document: Compare the total score to the interpretation thresholds. Document it in the patient’s clinical record along with the date, score, and clinical impression. Flag scores of 5 or above for further assessment or referral.

Scoring and interpreting GDS results

Scoring the geriatric depression scale is simple: each answer indicating depression receives 1 point, and the total is compared against severity thresholds. Interpretation varies between the GDS-30 and GDS-15 versions because the denominator differs.

GDS-15 Score Interpretation Clinical Action
0-4 Normal / No depression Routine monitoring; repeat annually or per protocol
5-8 Mild depression Counseling, lifestyle interventions, or referral for further assessment
9-11 Moderate depression Urgent referral to mental health specialist; consider pharmacotherapy
12-15 Severe depression Immediate psychiatric referral; assess for suicide risk and safety

GDS-30 interpretation: scores of 0-9 indicate normal mood, 10-19 mild depression, and 20-30 severe depression. The thresholds shift because the full-scale version has double the items.

Pro Tip

Document GDS scores alongside PHQ-9 or other mood measures if available. GDS alone captures general depression risk, but serial GDS-15 scores every 6-12 months in stable patients, or every 2-4 weeks in those on antidepressant therapy, provide clinically actionable trend data for medication efficacy and safety monitoring.

Who the GDS is right for, and who it isn’t

The geriatric depression scale is validated for community-dwelling and institutionalized older adults aged 55 and above. It works well for patients with mild-to-moderate cognitive impairment. Significant limitations exist in populations with major cognitive decline.

  • Appropriate populations: Community-living older adults, primary care patients, long-term care residents, post-acute rehabilitation settings, and older adults with chronic medical conditions (diabetes, heart disease, arthritis).
  • Contraindications: Moderate-to-severe dementia, severe hearing loss without accommodation, acute delirium, and non-English-speaking patients without validated translated versions. GDS reliability drops sharply as global cognitive decline worsens.
  • Alternative tools: In patients with moderate-to-severe dementia, the Cornell Scale for Depression in Dementia or other specialist assessment tools may be more appropriate.

GDS limitations and alternative screening tools

Despite its widespread use, the geriatric depression scale has documented limitations. The scale shows ceiling effects in patients with dementia. Cognitive impairment can prevent accurate self-reporting of mood symptoms, leading to falsely low scores. The GDS also emphasizes mood over somatic symptoms. This can miss depression presentations dominated by physical complaints (fatigue, pain, insomnia) common in medically complex elderly patients.

For older adults with multiple comorbidities, the PHQ-9 (Patient Health Questionnaire-9) offers more detailed symptom tracking and suicide risk assessment. For dementia populations, the Cornell Scale incorporates caregiver observations and behavioral signs alongside patient self-report, improving diagnostic accuracy.

Psychometric properties: Reliability, validity, sensitivity, and specificity

The geriatric depression scale has strong evidence supporting its reliability and validity. Internal consistency (Cronbach’s alpha) ranges from 0.84-0.94 across diverse samples. Test-retest reliability over 1-week intervals exceeds 0.80, demonstrating stable measurement.

Sensitivity, the ability to correctly identify patients with depression, ranges from 0.80-0.95 for the GDS-15 against clinical depression diagnoses across different settings. Specificity, correctly identifying non-depressed patients, similarly ranges from 0.80-0.95. These high indices support its use as both a screening tool and a treatment-monitoring measure.

The GDS performs well across age groups (65-100+ years), multiple countries and languages, and diverse ethnic groups. This supports its wide adoption as a first-line depression screen.

How Pabau supports GDS screening and tracking

Paper-based GDS tracking makes it hard to spot a trend across visits, since each form sits in a separate folder or scanned file. Practice management software like Pabau keeps every score in the same record as the appointment it was taken at. A rising trend is visible at a glance.

Digital forms let patients complete the GDS-15 on a tablet or mobile device in the waiting room. The form auto-scores and populates the result directly into their clinical notes, cutting the admin work of manual scoring and data entry.

Digital forms
Pabau’s digital forms let patients complete the GDS-15 on a tablet before their visit. The score is already in the chart when the appointment starts.

Automated follow-up communications can remind patients to return for reassessment at recommended intervals. This helps depression screening become a sustainable part of chronic disease management rather than a one-time event.

SMS Broadcast
Pabau’s automated SMS reminders prompt patients to return for their next GDS reassessment, so follow-up screening happens on schedule without staff chasing it manually.

Every score is stored in a HIPAA-compliant record, preserving confidentiality while still supporting quality-improvement reviews across a caseload.

Streamline mood assessments with Pabau

Store, track, and trend geriatric depression scale scores within your patient records. Digital forms auto-score results and trigger follow-up reminders automatically.

Pabau clinical management interface

Conclusion

The geriatric depression scale remains one of the most validated and widely used depression screening tools for older adults. Its simplicity, brevity, and proven reliability make it a strong first-line assessment in primary care, mental health, and long-term care settings.

Digital tracking turns a single score into a usable trend. That trend shows whether a patient is improving or needs a referral. Book a demo to see how Pabau’s digital forms and patient records support depression screening workflows for older adults.

Continue your research

Continue your research

Need a framework for psychiatric evaluation? Psychiatric evaluation template walks through comprehensive mental health assessment structure.

Looking for another validated assessment tool? Vanderbilt ADHD rating scale scoring guide covers age-specific behavioral assessment for clinicians.

Want to improve clinical documentation quality? Safer clinical notes guide ensures assessment results are recorded clearly and defensibly.

Frequently asked questions

What is the purpose of the Geriatric Depression Scale?

The GDS is a validated screening tool designed to identify depression in older adults aged 55 and above. It uses a simple yes/no format to reduce cognitive burden and distinguish depression symptoms from normal aging or medical comorbidities. This enables early detection and intervention in primary care, mental health, and long-term care settings.

What is a normal GDS score?

For the GDS-15 short form, scores of 0-4 are considered normal with no depression. Scores 5-8 indicate mild depression, 9-11 moderate depression, and 12-15 severe depression. Scores of 5 or above warrant further assessment or referral to a mental health professional.

What is the difference between GDS-30 and GDS-15?

The GDS-30 is the original 30-item version developed in 1982, requiring 10-15 minutes for administration. The GDS-15 is a 15-item short form released in 1986 that takes 5-10 minutes. Both are validated; the choice depends on available time and setting. GDS-15 is preferred for routine primary care screening, while GDS-30 suits comprehensive psychiatric assessment.

How do you score the GDS-15 short form?

Count each answer indicating depression as 1 point (typically yes/no responses are recorded, and depression-indicating answers receive points). Sum the total and compare to thresholds: 0-4 normal, 5-8 mild, 9-11 moderate, 12-15 severe. Enter the score and date into the patient’s clinical record and act on results (scores of 9 or above warrant referral).

Is the GDS valid for patients with dementia?

The GDS has limited reliability in moderate-to-severe dementia. Cognitive impairment reduces the patient’s ability to accurately report mood symptoms, leading to falsely low scores. For dementia populations, the Cornell Scale for Depression in Dementia is preferred because it incorporates caregiver observation and behavioral signs alongside patient self-report.

What is the GDS-5 and when should it be used?

The GDS-5 is an ultra-short 5-item version of the scale requiring only 2-3 minutes to administer. It is best suited for rapid screening in emergency departments, acute care hospitals, or time-limited clinic settings where full GDS-15 administration is impractical. It sacrifices some sensitivity for speed, so positive screens still require the longer version for confirmation.

Found our content helpful?
×